» Articles » PMID: 3085094

Fc Receptor Triggering Induces Expression of Surface Activation Antigens and Release of Platelet-activating Factor in Large Granular Lymphocytes

Overview
Specialty Science
Date 1986 Apr 1
PMID 3085094
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Triggering of large granular lymphocyte (LGL) Fc receptor with a specific monoclonal antibody (AB8.28) linked to an insoluble matrix induces cell activation, as witnessed by expression of HLA class II (DR and DQ) molecules and interleukin 2 receptor. Moreover, this event is accompanied by a concomitant release of platelet-activating factor by LGL. We conclude that the Fc receptor molecule identified by mAb AB8.28 represents a trigger for LGL activation.

Citing Articles

Functional regulation of human neutrophil Fc gamma receptors.

Selvaraj P, Fifadara N, Nagarajan S, Cimino A, Wang G Immunol Res. 2004; 29(1-3):219-30.

PMID: 15181284 DOI: 10.1385/IR:29:1-3:219.


Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages.

Watanabe M, Yamada M, MUE S, Ohuchi K Br J Pharmacol. 1995; 116(3):2141-7.

PMID: 8640357 PMC: 1908933. DOI: 10.1111/j.1476-5381.1995.tb16423.x.


Differences in the mechanism of induction of interferon-alpha by herpes simplex virus and herpes simplex virus-infected cells.

Capobianchi M, Malavasi F, Di Marco P, Dianzani F Arch Virol. 1988; 103(3-4):219-29.

PMID: 2850784 DOI: 10.1007/BF01311094.


The potential pathophysiological role of platelet-activating factor in human diseases.

Kroegel C Klin Wochenschr. 1988; 66(9):373-8.

PMID: 2839728 DOI: 10.1007/BF01737939.


The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.

Mandi Y, Farkas G, Koltai M, BELADI I, Mencia-Huerta J, Braquet P Immunology. 1989; 67(3):370-4.

PMID: 2759659 PMC: 1385355.


References
1.
Henson P . Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion. J Clin Invest. 1977; 60(2):481-90. PMC: 372391. DOI: 10.1172/JCI108799. View

2.
Malavasi F, Funaro A, Bellone G, Caligaris-Cappio F, Berti E, Tetta C . Functional and molecular characterization by the CB04 monoclonal antibody of a cell surface structure exerting C3-complement receptor activity. J Clin Immunol. 1985; 5(6):412-20. DOI: 10.1007/BF00915339. View

3.
Pinckard R, Farr R, HANAHAN D . Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol. 1979; 123(4):1847-57. View

4.
Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C . Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology. 1981; 42(2):191-9. PMC: 1458080. View

5.
GOLDMAN D, Goetzl E . Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. J Immunol. 1982; 129(4):1600-4. View